Skip to main content
Log in

Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The plasma concentration curves and urinary excretion of oxmetidine after administration of single i.v. (100 mg) and oral (200 mg) doses have been studied in 11 patients with peptic ulcer disease. The mean bioavailability of the drug was 70% (range 53–91%). After intravenous administration, the mean plasmat 1/2β was 3.0 h, the mean apparent volume of distribution 0.7 l/kg, the mean total plasma clearance 12.3 l/h and the mean plasma renal clearance was 0.7 l/h. Following intravenous and oral administration an average of 6% and 3%, respectively, of unchanged drug was found in the urine. The plasma concentration curve after oral administration in most patients exhibited two maxima, with peak concentrations appearing between 45 and 210 min after dosing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bodemar G, Norlander B, Fransson L, Walan A (1979) The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on absorption of cimetidine-studies in patients with peptic ulcer disease. Br J Clin Pharmacol 7: 23–31

    Google Scholar 

  2. Bodemar G, Norlander B, Walan A (1981) Pharmacokinetics of cimetidine after single doses and during continous treatment. Clin Pharmacokinet 6: 306–315

    Google Scholar 

  3. Gugler R, Somogyi A, Bergman Kv (1981) The biliary excretion of histamine H2-receptor antagonists cimetidine and oxmetidine. Clin Pharmacol Ther 29: 249–250

    Google Scholar 

  4. Mills JG, Brunet PL, Griffiths R, Hunt RH, Vincent D, Milton-Thompson GJ, Burland WL (1982) Oxmetidine-clinical pharmacological studies with a new H2-receptor antagonist. Gut 23: 157–163

    Google Scholar 

  5. Porro BG, Petrillo M, Lazzaroni M, Leto di Priolo S (1981) Healing of duodenal ulcer with twice daily oxmetidine, Part 2. In: Baron JH (ed) Cimetidine in the 80's. Churchill Livingstone, Edinburgh London Melbourne New York

    Google Scholar 

  6. Rohner HG, Brandstätter G, Kratochvil P, Kollmeier J, Gugler R (1981) Healing of duodenal ulcer with twice daily oxmetidine, Part 1. In: Baron JH (ed) Cimetidine in the 80's. Churchill Livingstone, Edinburgh London Melbourne New York

    Google Scholar 

  7. Sharpe PC, Melvin MA, Mills JG, Burland WL, Groom CV (1980) Prolactin responses to histamin H2-receptor antagonists. Acta Endocrinol 95: 308–313

    Google Scholar 

  8. Somogyi A, Gugler R (1980) Gastric acid inhibitors effect and pharmacokinetics of a new histamine H2 antagonist, 92994. Hepatogastroenterology. Abstracts: XI Internat Congr of Gastroenterology E 32.13, p 260

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jönsson, K.Å., Bodemar, G., Gotthard, R. et al. Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses. Eur J Clin Pharmacol 24, 353–356 (1983). https://doi.org/10.1007/BF00610054

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00610054

Key words

Navigation